At a glance
ClinicalIndex Comparison RecordN/ACompleted· 194 enrolled
Drug / intervention
conventional rectal surgery +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Introduction of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer. Influence of This New Operation Technique on Local Recurrence and Long-Time Survival. Retrospective Study: 1993-2001
In Brief
An observational study evaluating conventional rectal surgery and total mesorectal excision for Rectal Cancer. Completed, enrolled 194 participants across 1 site.
Detailed Summary
Total mesorectal excision (TME) is a rather new operation technique in the treatment of rectal cancer. It is known to reduce the rate of local recurrences. However, the influence on long-term survival is unclear.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRectal Cancer
CountriesSwitzerland
Collaborators--
Timeline
N/ACompletedFinished
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 1993
Primary CompletionDec 2001
First PostedMay 2009
TodayJul 2026
First PostedMay 29, 2009
Enrollment StartJan 1, 1993
Primary CompletionDec 1, 2001
TodayJul 2, 2026
Enrollment to primary: 8.9 yearsPosted 17.1 years ago
Interventions
conventional rectal surgeryprocedure
type of rectal surgery before the introduction of TME
total mesorectal excisionprocedure
total mesorectal excision